A move to allow pharmacists to administer more vaccines could have a profound effect on adult vaccination rates and vaccine-preventable disease prevalence.
New vaccines that use antibodies to prevent opioids from causing a “high” could help stem abuse and fatal overdoses if human trials are successful.
Tracking, reporting, and organizing immunization-related data is difficult but can improve patient care. HIMSS has recognized several products through its voluntary testing program that can do that job and work with electronic health record systems.
A therapy that uses the immune system to fight cancer has been 97% effective in mice and is moving to human trials.
There is a new vaccine against shingles, and ACIP has recommended that it replace its predecessor.
A new program developed with the support of CDC aims to streamline vaccine-related functions in EHRs to make administration and reporting easier for clinicians.
Patients are increasingly turning to the Internet to have questions about vaccines answered, highlighting the need for increased education at the time of vaccination.
A new study reveals that certain genes may play a role in how effectively the body produces antibodies against the flu after vaccination.
Imagine if you could administer an entire vaccine series in just one shot. That technology might be on the horizon, thanks to researchers at MIT.
Adults who don’t know they need or refuse measles vaccinations before international travel introduce more than half of new U.S. measles cases.